549 results on '"Feng, Zijian"'
Search Results
202. Indications that Live Poultry Markets Are a Major Source of Human H5N1 Influenza Virus Infection in China
- Author
-
Wan, Xiu-Feng, primary, Dong, Libo, additional, Lan, Yu, additional, Long, Li-Ping, additional, Xu, Cuiling, additional, Zou, Shumei, additional, Li, Zi, additional, Wen, Leying, additional, Cai, Zhipeng, additional, Wang, Wei, additional, Li, Xiaodan, additional, Yuan, Fan, additional, Sui, Hongtao, additional, Zhang, Ye, additional, Dong, Jie, additional, Sun, Shanhua, additional, Gao, Yan, additional, Wang, Min, additional, Bai, Tian, additional, Yang, Lei, additional, Li, Dexin, additional, Yang, Weizhong, additional, Yu, Hongjie, additional, Wang, Shiwen, additional, Feng, Zijian, additional, Wang, Yu, additional, Guo, Yuanji, additional, Webby, Richard J., additional, and Shu, Yuelong, additional
- Published
- 2011
- Full Text
- View/download PDF
203. Laboratory-Based Surveillance of NontyphoidalSalmonellaInfections in China
- Author
-
Ran, Lu, primary, Wu, Shuyu, additional, Gao, Yongjun, additional, Zhang, Xin, additional, Feng, Zijian, additional, Wang, Zijun, additional, Kan, Biao, additional, Klena, John D., additional, Lo Fo Wong, Danilo M.A., additional, Angulo, Frederick J., additional, and Varma, Jay K., additional
- Published
- 2011
- Full Text
- View/download PDF
204. Automatic classification of uncertain data by soft classifier
- Author
-
Li, Le, primary, Yu, Zhiwen, additional, Feng, Zijian, additional, and Zhang, Xiaohang, additional
- Published
- 2011
- Full Text
- View/download PDF
205. USOM: Mining and visualizing uncertain data based on self-organizing maps
- Author
-
Li, Le, primary, Zhang, Xiaohang, additional, Yu, Zhiwen, additional, Feng, Zijian, additional, and Wei, Ruiping, additional
- Published
- 2011
- Full Text
- View/download PDF
206. The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China
- Author
-
Xu, Cuiling, primary, Bai, Tian, additional, Iuliano, A. Danielle, additional, Wang, Min, additional, Yang, Lei, additional, Wen, Leying, additional, Zeng, Yuhong, additional, Li, Xiaodan, additional, Chen, Tao, additional, Wang, Wei, additional, Hu, Ying, additional, Yang, Limei, additional, Li, Zi, additional, Zou, Shumei, additional, Li, Dexin, additional, Wang, Shiwen, additional, Feng, Zijian, additional, Zhang, Yanping, additional, Yu, Hongjie, additional, Yang, Weizhong, additional, Wang, Yu, additional, Widdowson, Marc-Alain, additional, and Shu, Yuelong, additional
- Published
- 2011
- Full Text
- View/download PDF
207. Gaps Remain In China’s Ability To Detect Emerging Infectious Diseases Despite Advances Since The Onset Of SARS And Avian Flu
- Author
-
Feng, Zijian, primary, Li, Wenkai, additional, and Varma, Jay K., additional
- Published
- 2011
- Full Text
- View/download PDF
208. A Systematic Molecular Pathology Study of a Laboratory Confirmed H5N1 Human Case
- Author
-
Gao, Rongbao, primary, Dong, Libo, additional, Dong, Jie, additional, Wen, Leying, additional, Zhang, Ye, additional, Yu, Hongjie, additional, Feng, Zijian, additional, Chen, Minmei, additional, Tan, Yi, additional, Mo, Zhaojun, additional, Liu, Haiyan, additional, Fan, Yunyan, additional, Li, Kunxiong, additional, Li, Chris Ka-Fai, additional, Li, Dexin, additional, Yang, Weizhong, additional, and Shu, Yuelong, additional
- Published
- 2010
- Full Text
- View/download PDF
209. Seasonal influenza vaccine supply and target vaccinated population in China, 2004–2009
- Author
-
Feng, Luzhao, primary, Mounts, Anthony Wayne, additional, Feng, Yunxia, additional, Luo, Yuan, additional, Yang, Peng, additional, Feng, Zijian, additional, Yang, Weizhong, additional, and Yu, Hongjie, additional
- Published
- 2010
- Full Text
- View/download PDF
210. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China
- Author
-
Zhang, Yan, primary, Zhu, Zhen, additional, Yang, Weizhong, additional, Ren, Jun, additional, Tan, Xiaojuan, additional, Wang, Yu, additional, Mao, Naiying, additional, Xu, Songtao, additional, Zhu, Shuangli, additional, Cui, Aili, additional, Zhang, Yong, additional, Yan, Dongmei, additional, Li, Qun, additional, Dong, Xiaoping, additional, Zhang, Jing, additional, Zhao, Yueping, additional, Wan, Junfeng, additional, Feng, Zijian, additional, Sun, Junling, additional, Wang, Shiwen, additional, Li, Dexin, additional, and Xu, Wenbo, additional
- Published
- 2010
- Full Text
- View/download PDF
211. Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis
- Author
-
Tomi Sunagawa, Patricia Santa-Olalla, Darren Hunt, Rhonda Owen, Isabelle Bonmarin, Yu Hongjie, Juno Thomas, Jeffrey Cutter, Artemis Koukounari, Katelijn Vandemaele, Maria D. Van Kerkhove, Silke Buda, Albert Ka-Wing Au, Vivek Shinde, Kumnuan Ungchusak, Richard Pebody, Arnaud Orelle, Christl A. Donnelly, Claudia González, Gérard Krause, C. C. H. Lieke Wielders, Walter Haas, Luis O. Carlino, Yoshihiro Takayama, Kiyosu Taniguichi, Kensuke Nakajima, Shuk Kwan Chuang, Feng Zijian, Louise Pelletier, Tokuaki Shobayashi, Seema Jain, Beverly Paterson, Julie Vachon, Anthony W. Mounts, Maria J. Sierra-Moros, Marianne A B van der Sande, Wanna Hanshaoworakul, Vernon J. Lee, Giovanna Jaramillo-Gutierrez, Jean-Michel Heraud, Ethel Palacios, Medical Research Council (MRC), Department of Infectious Disease Epidemiology [London] (DIDE), Imperial College London, Global Influenza Programme, Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Ministerio de Salud de la Nacion, Department of Health and Ageing, Influenza Surveillance Section, Surveillance Branch, Office of Health Protection (DHAISS), Department of Health and Ageing, Influenza Surveillance Section, Surveillance Branch, Office of Health Protection, Woden, ACT, Australia, Public Health Agency of Canada, Departamento de Epidemiologıa, Division de Planificacion Sanitaria, Ministerio de Salud de Chile, Chinese Center for Disease Control and Prevention, Surveillance and Epidemiology Branch, Centre for Health Protection of Department of Health, Robert Koch Institute [Berlin] (RKI), Département des maladies infectieuses, Institut de Veille Sanitaire (INVS), Infectious Disease Surveillance Center, National Institute of Infectious Diseases [Tokyo], Ministry of Health, Labour and Welfare, Institut Pasteur de Madagascar, Réseau International des Instituts Pasteur (RIIP), Directorate General of Epidemiology, National Institute for Public Health and the Environment [Bilthoven] (RIVM), New Zealand Ministry of Health, Communicable Diseases Division at the Ministry of Health, Biodefence Centre, Ministry of Defence, Yong Loo Lin School of Medicine [Singapore], Epidemiology and Surveillance Unit, Respiratory Virus Unit, National Institute for Communicable Diseases [Johannesburg] (NICD), Coordinating centre for Health Alerts and Emergencies, Direccion General de Salud Publica y Sanidad Exterior Ministerio de Sanidad y Polıtica Social, Bureau of Vector Borne Disease, Department of Disease Control, Ministry of Public Health - Thailande, Health Protection Agency, Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention (CDC), MDVK, CAD, and AK acknowledge funding from the Medical Research Council UK and the Bill and Melinda Gates Foundation (MDVK) for funding, and on behalf of the WHO Working Group for Risk Factors for Severe H1N1pdm Infection
- Subjects
Male ,NEW-ZEALAND ,A(H1N1) INFECTION ,MESH: Global Health ,Global Health ,Body Mass Index ,HOSPITALIZED-PATIENTS ,MESH: Pregnancy ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Pregnancy ,MESH: Child ,Odds Ratio ,Young adult ,Child ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,0303 health sciences ,education.field_of_study ,MESH: Middle Aged ,MESH: Influenza, Human ,11 Medical And Health Sciences ,General Medicine ,3. Good health ,MESH: Young Adult ,Child, Preschool ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,World Health ,Medicine ,Public Health ,MESH: Pandemics ,medicine.medical_specialty ,MESH: Body Mass Index ,MESH: Influenza A Virus, H1N1 Subtype ,03 medical and health sciences ,Intensive care ,SURVEILLANCE ,Humans ,Risk factor ,education ,MESH: Prevalence ,Aged ,MESH: Adolescent ,MESH: Humans ,Science & Technology ,030306 microbiology ,MESH: Child, Preschool ,MESH: Adult ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,WHO Working Group for Risk Factors for Severe H1N1pdm Infection ,Odds ratio ,Influenza ,Relative risk ,RA Public aspects of medicine ,MESH: Data Interpretation, Statistical ,MESH: Female ,Body mass index ,Demography ,Viral Diseases ,Pediatrics ,MESH: Hospitalization ,Influenza A Virus, H1N1 Subtype ,MESH: Risk Factors ,Risk Factors ,Epidemiology ,Prevalence ,ADULT PATIENTS ,030212 general & internal medicine ,MESH: Aged ,Middle Aged ,Hospitalization ,Intensive Care Units ,Infectious Diseases ,Data Interpretation, Statistical ,Female ,Life Sciences & Biomedicine ,CRITICALLY-ILL PATIENTS ,PREGNANT-WOMEN ,Research Article ,Adult ,Adolescent ,Population ,UNITED-STATES ,macromolecular substances ,VIRUS-INFECTION ,PANDEMIC INFLUENZA ,Young Adult ,Medicine, General & Internal ,General & Internal Medicine ,Influenza, Human ,medicine ,Pandemics ,business.industry ,MESH: Chronic Disease ,MESH: Male ,MESH: Odds Ratio ,Chronic Disease ,MESH: Intensive Care Units ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business - Abstract
This study analyzes data from 19 countries (from April 2009 to Jan 2010), comprising some 70,000 hospitalized patients with severe H1N1 infection, to reveal risk factors for severe pandemic influenza, which include chronic illness, cardiac disease, chronic respiratory disease, and diabetes., Background Since the start of the 2009 influenza A pandemic (H1N1pdm), the World Health Organization and its member states have gathered information to characterize the clinical severity of H1N1pdm infection and to assist policy makers to determine risk groups for targeted control measures. Methods and Findings Data were collected on approximately 70,000 laboratory-confirmed hospitalized H1N1pdm patients, 9,700 patients admitted to intensive care units (ICUs), and 2,500 deaths reported between 1 April 2009 and 1 January 2010 from 19 countries or administrative regions—Argentina, Australia, Canada, Chile, China, France, Germany, Hong Kong SAR, Japan, Madagascar, Mexico, the Netherlands, New Zealand, Singapore, South Africa, Spain, Thailand, the United States, and the United Kingdom—to characterize and compare the distribution of risk factors among H1N1pdm patients at three levels of severity: hospitalizations, ICU admissions, and deaths. The median age of patients increased with severity of disease. The highest per capita risk of hospitalization was among patients, Editors' Summary Background In April 2009, a new strain of influenza A H1N1 was first identified in Mexico and the United States and subsequently spread around the world. In June 2009, the World Health Organization (WHO) declared a pandemic alert phase 6, which continued until August 2010. Throughout the pandemic, WHO and member states gathered information to characterize the patterns of risk associated with the new influenza A H1N1 virus infection and to assess the clinical picture. Although risk factors for severe disease following seasonal influenza infection have been well documented in many countries (for example, pregnancy; chronic medical conditions such as pulmonary, cardiovascular, renal, hepatic, neuromuscular, hematologic, and metabolic disorders; some cognitive conditions; and immunodeficiency), risk factors for severe disease following infection early in the 2009 H1N1 pandemic were largely unknown. Why Was This Study Done? Many countries have recently reported data on the association between severe H1N1 influenza and a variety of underlying risk factors, but because these data are presented in different formats, making direct comparisons across countries is difficult, with no clear consensus for some conditions. Therefore, to assess the frequency and distribution of known and new potential risk factors for severe H1N1 infection, this study was conducted to collect data (from 1 April 2009 to 1 January 2010) from surveillance programs of the Ministries of Health or National Public Health Institutes in 19 countries―Argentina, Australia, Canada, Chile, China, France, Germany, Hong Kong (special administrative region), Japan, Madagascar, Mexico, the Netherlands, New Zealand, Singapore, South Africa, Spain, Thailand, the United States, and the United Kingdom. What Did the Researchers Do and Find? As part of routine surveillance, countries were asked to provide risk factor data on laboratory-confirmed H1N1 in patients who were admitted to hospital, admitted to the intensive care unit (ICU), or had died because of their infection, using a standardized format. The researchers grouped potential risk conditions into four categories: age, chronic medical illnesses, pregnancy (by trimester), and other conditions that were not previously considered as risk conditions for severe influenza outcomes, such as obesity. For each risk factor (except pregnancy), the researchers calculated the percentage of each group of patients using the total number of cases reported in each severity category (hospitalization, admission to ICU, and death). To evaluate the risk associated with pregnancy, the researchers used the ratio of pregnant women to all women of childbearing age (age 15–49 years) at each level of severity to describe the differences between levels. The researchers were able to collect data on approximately 70,000 patients requiring hospitalization, 9,700 patients admitted to the ICU, and 2,500 patients who died from H1N1 infection. The proportion of patients with H1N1 with one or more reported chronic conditions increased with severity—the median was 31.1% of hospitalized patients, 52.3% of patients admitted to the ICU, and 61.8% of patients who died. For all levels of severity, pregnant women in their third trimester consistently accounted for the majority of the total of pregnant women. The proportion of patients with obesity increased with increasing disease severity—median of 6% of hospitalized patients, 11.3% of patients admitted to the ICU, and 12.0% of all deaths from H1N1. What Do These Findings Mean? These findings show that risk factors for severe H1N1 infection are similar to those for seasonal influenza, with some notable differences: a substantial proportion of people with severe and fatal cases of H1N1 had pre-existing chronic illness, which indicates that the presence of chronic illness increases the likelihood of death. Cardiac disease, chronic respiratory disease, and diabetes are important risk factors for severe disease that will be especially relevant for countries with high rates of these illnesses. Approximately 2/3 of hospitalized people and 40% of people who died from H1N1 infection did not have any identified pre-existing chronic illness, but this study was not able to comprehensively assess how many of these cases had other risk factors, such as pregnancy, obesity, smoking, and alcohol misuse. Because of large differences between countries, the role of risk factors such as obesity and pregnancy need further study—although there is sufficient evidence to support vaccination and early intervention for pregnant women. Overall, the findings of this study reinforce the need to identify and target high-risk groups for interventions such as immunization, early medical advice, and use of antiviral medications. Additional Information Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001053. WHO provides a Global Alert and Response (GAR) with updates on a number of influenza-related topics The US Centers for Disease Control and Prevention provides information on risk factors and H1N1
- Published
- 2011
212. Risk Factors for Injury During Typhoon Saomei
- Author
-
Shen, Jinyu, primary, Feng, Zijian, additional, Zeng, Guang, additional, and Zhu, Bao-Ping, additional
- Published
- 2009
- Full Text
- View/download PDF
213. Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China
- Author
-
Yu, Hongjie, primary, Gao, Zhancheng, additional, Feng, Zijian, additional, Shu, Yuelong, additional, Xiang, Nijuan, additional, Zhou, Lei, additional, Huai, Yang, additional, Feng, Luzhao, additional, Peng, Zhibin, additional, Li, Zhongjie, additional, Xu, Cuiling, additional, Li, Junhua, additional, Hu, Chengping, additional, Li, Qun, additional, Xu, Xiaoling, additional, Liu, Xuecheng, additional, Liu, Zigui, additional, Xu, Longshan, additional, Chen, Yusheng, additional, Luo, Huiming, additional, Wei, Liping, additional, Zhang, Xianfeng, additional, Xin, Jianbao, additional, Guo, Junqiao, additional, Wang, Qiuyue, additional, Yuan, Zhengan, additional, Zhou, Longnv, additional, Zhang, Kunzhao, additional, Zhang, Wei, additional, Yang, Jinye, additional, Zhong, Xiaoning, additional, Xia, Shichang, additional, Li, Lanjuan, additional, Cheng, Jinquan, additional, Ma, Erdang, additional, He, Pingping, additional, Lee, Shui Shan, additional, Wang, Yu, additional, Uyeki, Timothy M., additional, and Yang, Weizhong, additional
- Published
- 2008
- Full Text
- View/download PDF
214. Enhanced catalytic activity for NO oxidation over Ba doped LaCoO3 catalyst.
- Author
-
Zhou, Chen, Feng, Zijian, Zhang, Yexin, Hu, Lingjun, Chen, Rong, Shan, Bin, Yin, Hongfeng, Wang, Wei Guo, and Huang, Aisheng
- Published
- 2015
- Full Text
- View/download PDF
215. Promotional role of La addition in the NO oxidation performance of a SmMn2O5mullite catalystElectronic supplementary information (ESI) available: Detailed kinetic test conditions, catalytic performance of individual oxides, NO-TPD results, DRIFTS study on the catalysts, etc.See DOI: 10.1039/c5cy01919b
- Author
-
Feng, Zijian, Wang, Jianqiang, Liu, Xiao, Wen, Yanwei, Chen, Rong, Yin, Hongfeng, Shen, Meiqing, and Shan, Bin
- Abstract
A series of LaxSm1−xMn2Oδ(x= 0, 0.1, 0.3, 0.5) catalysts were synthesized through a co-precipitation method. The catalytic activity for NO oxidation was enhanced with La substitution, and the maximum activity was achieved at x= 0.3. XRD and HRTEM results revealed the formation of a multiphase oxide as well as the interface structure between the mullite (SmMn2O5) phase and Mn-rich perovskite (La0.96MnO3.05) phase. The main impact of different La/Sm molar ratios is the amount of surface adsorbed oxygen (Oads) and surface Mn4+ions as revealed by XPS results. The NO oxidation performance was enhanced through La addition by promoting the decomposition of nitrate/nitrite species and desorption of NO2, improving the reducibility of surface adsorbed oxygen, as determined by H2-TPR, NO + O2-TPRD and in situDRIFTS studies. Mono-, bi-dentate and bridged nitrates formed on the surface were determined to be the primary reaction intermediates.
- Published
- 2016
- Full Text
- View/download PDF
216. Hand, foot, and mouth disease in China: patterns of spread and transmissibility.
- Author
-
Wang, Yu, Feng, Zijian, Yang, Yang, Self, Steve, Gao, Yongjun, Longini, Ira M., Wakefield, Jon, Zhang, Jing, Wang, Liping, Chen, Xi, Yao, Lena, Stanaway, Jeffrey D., Wang, Zijun, and Yang, Weizhong
- Published
- 2011
- Full Text
- View/download PDF
217. Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis.
- Author
-
Van Kerkhove, Maria D., Vandemaele, Katelijn A. H., Shinde, Vivek, Jaramillo-Gutierrez, Giovanna, Koukounari, Artemis, Donnelly, Christl A., Carlino, Luis O., Owen, Rhonda, Paterson, Beverly, Pelletier, Louise, Vachon, Julie, Gonzalez, Claudia, Yu Hongjie, Feng Zijian, Shuk Kwan Chuang, Au, Albert, Buda, Silke, Krause, Gerard, Haas, Walter, and Bonmarin, Isabelle
- Subjects
H1N1 influenza ,DISEASE risk factors ,QUANTITATIVE research ,INTENSIVE care units - Abstract
Background: Since the start of the 2009 influenza A pandemic (H1N1pdm), the World Health Organization and its member states have gathered information to characterize the clinical severity of H1N1pdm infection and to assist policy makers to determine risk groups for targeted control measures. Methods and Findings: Data were collected on approximately 70,000 laboratory-confirmed hospitalized H1N1pdm patients, 9,700 patients admitted to intensive care units (ICUs), and 2,500 deaths reported between 1 April 2009 and 1 January 2010 from 19 countries or administrative regions-Argentina, Australia, Canada, Chile, China, France, Germany, Hong Kong SAR, Japan, Madagascar, Mexico, the Netherlands, New Zealand, Singapore, South Africa, Spain, Thailand, the United States, and the United Kingdom-to characterize and compare the distribution of risk factors among H1N1pdm patients at three levels of severity: hospitalizations, ICU admissions, and deaths. The median age of patients increased with severity of disease. The highest per capita risk of hospitalization was among patients ,5 y and 5-14 y (relative risk [RR] = 3.3 and 3.2, respectively, compared to the general population), whereas the highest risk of death per capita was in the age groups 50-64 y and ≥65 y (RR = 1.5 and 1.6, respectively, compared to the general population). Similarly, the ratio of H1N1pdm deaths to hospitalizations increased with age and was the highest in the ≥65-y-old age group, indicating that while infection rates have been observed to be very low in the oldest age group, risk of death in those over the age of 64 y who became infected was higher than in younger groups. The proportion of H1N1pdm patients with one or more reported chronic conditions increased with severity (median = 31.1%, 52.3%, and 61.8% of hospitalized, ICU-admitted, and fatal H1N1pdm cases, respectively). With the exception of the risk factors asthma, pregnancy, and obesity, the proportion of patients with each risk factor increased with severity level. For all levels of severity, pregnant women in their third trimester consistently accounted for the majority of the total of pregnant women. Our findings suggest that morbid obesity might be a risk factor for ICU admission and fatal outcome (RR = 36.3). Conclusions: Our results demonstrate that risk factors for severe H1N1pdm infection are similar to those for seasonal influenza, with some notable differences, such as younger age groups and obesity, and reinforce the need to identify and protect groups at highest risk of severe outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
218. Characterization of Hand, Foot, and Mouth Disease in China between 2008 and 2009.
- Author
-
ZHANG, Jing, SUN, JunLing, CHANG, ZhaoRui, ZHANG, WeiDong, WANG, ZiJun, and FENG, ZiJian
- Abstract
Abstract: Objective: To investigate the epidemiological and clinical features of hand, foot and mouth disease (HFMD) since several outbreaks of HFMD caused by enteroviruses were documented in China between 2007 and 2008. Methods: HFMD cases reported to the National Infectious Disease Information Management System database between May 2008 and April 2009 were assessed. Clinical features in some of the severe and fatal cases were analyzed the etiology of the outbreaks was investigated. Results: 89.1% of reported HFMD cases were found in children<5 year-old with an age-specific incidence rate of 834.1/100 000 in the first year as the notifiable disease in China from May 2008 to April 2009. The incidence, mortality and percentage of severe cases were studied for three regions of China and found to be highest in the central region. The incidence of severe cases and mortality in rural population were significantly higher than those in urban population. Among the laboratory confirmed EV17 positive cases there were 52.6% mild, 83.5% severe, and 96.1% fatal cases. More myoclonic jerks were found in the severe case group than in group that died. Tachypnea, lip purpling, pink foaming and low limb temperature occurred more frequently in the fatal cases than in the severe cases. Conclusion: The epidemic of HFMD in China was characterized predominantly by EV71 infections, had relatively high mortality rates especially in the central region, and was most prevalent in young, rural populations. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
219. External quality assessment of the detection of rickettsioses in China.
- Author
-
Zhang, Lijuan, Ni, Daxin, and Feng, Zijian
- Subjects
RICKETTSIAL diseases ,SEROLOGY ,IMMUNOGLOBULINS ,IMMUNOFLUORESCENCE ,DNA - Abstract
Objective: To report a training course on the laboratory diagnoses of rickettsioses that 10 provincial/city CDCs participated in laboratory external quality assurance (EQA) based on the serological specific antibodies detection and rapid PCR amplifying targeted genes of rickettsiae. Methods: An EQA program to evaluate the following laboratory procedures was developed to detect rickettsiae: (1) immunofluorescent assay (IFA) to detect specific antibodies of A. phagocytophilum, R. heilongjiangensis and O. tsutsugamshi respectively.(2) Two sets of nested PCR were used amplifying groEL genes for most members of the family Rickettsiaceae and amplifying 16SrRNA genes for the most members of family anaplasmae, respectively. A scoring scheme based on the distribution of the median antibody titer values of the serologic assays was designed and a ranking list of the scores of the PCR results based on the detected minimal copy numbers of reference DNA was created. Results: Among nine laboratories who reported the results on time, eight laboratories gave acceptable serologic results, the other one provided an unacceptable antibody titer (1:2 vs median 1:64) results for O. tsutsugamshi. The limits of detection (LOD) for the PCR amplifying for five references DNA ranged from 1copy/μ L to 10
6 copy/μ L. Conclusion: We successfully trained and popularized modern diagnostic methods of rickettsiae in 10 provincial CDCs in China and first conducted the EQA projects and evaluated the results. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
220. Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006.
- Author
-
Yu, Hongjie, Feng, Zijian, Zhang, Xianfeng, Xiang, Nijuan, Huai, Yang, Zhou, Lei, Li, Zhongjie, Xu, Cuiling, Luo, Huiming, He, Jianfeng, Guan, Xuhua, Yuan, Zhengan, Li, Yanting, Xu, Longshan, Hong, Rongtao, Liu, Xuecheng, Zhou, Xingyu, Yin, Wenwu, Zhang, Shunxiang, and Shu, Yuelong
- Abstract
We investigated potential sources of infection for 6 confirmed influenza A (H5N1) patients who resided in urban areas of People's Republic of China. None had known exposure to sick poultry or poultry that died from illness, but all had visited wet poultry markets before illness. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
221. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study
- Author
-
Chen, HaiYing, Yuan, Hui, Gao, Rongbao, Zhang, Jinxiang, Wang, Dayan, Xiong, Ying, Fan, GuoYin, Yang, Fan, Li, Xiaodan, Zhou, Jianfang, Zou, Shumei, Yang, Lei, Chen, Tao, Dong, Libo, Bo, Hong, Zhao, Xiang, Zhang, Ye, Lan, Yu, Bai, Tian, Dong, Jie, Li, Qun, Wang, ShiWen, Zhang, YanPing, Li, Hui, Gong, Tian, Shi, Yong, Ni, Xiansheng, Li, Jianxiong, Zhou, Jun, Fan, Jiyi, Wu, Jingwen, Zhou, Xianfeng, Hu, Maohong, Wan, Jianguo, Yang, WeiZhong, Li, DeXin, Wu, Guizhen, Feng, ZiJian, Gao, George F, Wang, Yu, Jin, Qi, Liu, Mingbin, and Shu, Yuelong
- Abstract
Human infections with different avian influenza viruses—eg, H5N1, H9N2, and H7N9—have raised concerns about pandemic potential worldwide. We report the first human infection with a novel reassortant avian influenza A H10N8 virus.
- Published
- 2014
- Full Text
- View/download PDF
222. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study
- Author
-
Yu, Hongjie, Wu, Joseph T, Cowling, Benjamin J, Liao, Qiaohong, Fang, Vicky J, Zhou, Sheng, Wu, Peng, Zhou, Hang, Lau, Eric H Y, Guo, Danhuai, Ni, Michael Y, Peng, Zhibin, Feng, Luzhao, Jiang, Hui, Luo, Huiming, Li, Qun, Feng, Zijian, Wang, Yu, Yang, Weizhong, and Leung, Gabriel M
- Abstract
Transmission of the novel avian influenza A H7N9 virus seems to be predominantly between poultry and people. In the major Chinese cities of Shanghai, Hangzhou, Huzhou, and Nanjing—where most human cases of infection have occurred—live poultry markets (LPMs) were closed in April, 2013, soon after the initial outbreak, as a precautionary public health measure. Our objective was to quantify the effect of LPM closure in these cities on poultry-to-person transmission of avian influenza A H7N9 virus.
- Published
- 2014
- Full Text
- View/download PDF
223. Laboratory-Based Surveillance of Non-typhoidal SalmonellaInfections in Guangdong Province, China
- Author
-
Deng, Xiaoling, Ran, Lu, Wu, Shuyu, Ke, Bixia, He, Dongmei, Yang, Xingfen, Zhang, Yonghui, Ke, Changwen, Klena, John D., Yan, Meiying, Feng, Zijian, Kan, Biao, Liu, Xin, Mikoleit, Matthew, and Varma, Jay K.
- Abstract
AbstractSalmonellais one of the most common foodborne pathogens in humans. Laboratory-based surveillance for non-typhoidal Salmonellainfection was conducted in Guangdong Province, China to improve understanding about the disease burden and detection of dispersed outbreaks. Salmonellaisolated from patients with diarrhea were sent from 16 sentinel hospitals to local public health laboratories for confirmation, serotyping, antimicrobial susceptibility testing, and pulsed-field gel electrophoresis (PFGE). PFGE patterns were analyzed to identify clusters representing potential outbreaks. Between September 2009 and October 2010, 352 (4%) Salmonellaisolates were obtained from 9167 stool specimens. Salmonella entericaserotype Typhimurium (45%) and Salmonella entericaserotype Enteritidis (13%) were the most common serotypes, and multidrug resistance was high, especially in SalmonellaTyphimurium isolates. PFGE patterns of obtained Salmonellaisolates were found to be diverse, but a unique PFGE pattern comprising 53 SalmonellaTyphimurium isolates were found to occur almost exclusively in infants. Epidemiologic studies are ongoing to determine whether a common exposure is the source of the SalmonellaTyphimurium strain frequently isolated from infants.
- Published
- 2012
- Full Text
- View/download PDF
224. Laboratory-Based Surveillance of Nontyphoidal SalmonellaInfections in China
- Author
-
Ran, Lu, Wu, Shuyu, Gao, Yongjun, Zhang, Xin, Feng, Zijian, Wang, Zijun, Kan, Biao, Klena, John D., Lo Fo Wong, Danilo M.A., Angulo, Frederick J., and Varma, Jay K.
- Abstract
AbstractFoodborne infections are an important public health problem in China. In 2008, we conducted surveillance for laboratory-confirmed nontyphoidal Salmonellato monitor trends for this infection in China and to build capacity for rapid detection and response to foodborne outbreaks. Salmonellaisolates from patients with diarrhea were sent from hospitals to local public health laboratories for confirmation, serotyping, and antimicrobial susceptibility testing. A total of 126 hospitals in 44 cities and counties from 8 provinces provided isolates and epidemiologic data for analysis. Of 23,140 stool specimens submitted to clinical laboratories, 662 (3%) grew Salmonella enterica. Salmonellawere most commonly detected between April and October. The median age of infected patients was 27 years; 34% of infections occurred in patients <5 years old. Of the 662 isolates, we found 73 serotypes, of which serotype Enteritidis (31%) and serotype Typhimurium (26%) were the most common. The prevalence of resistance was high for clinically important antimicrobial agents, including ampicillin (41%) and ciprofloxacin (6%). More than 60% of isolates, including 35% of all Typhimurium, were resistant to three or more antimicrobial agents. In this first multiprovince surveillance report of laboratory-confirmed Salmonellainfections in China, we found that Enteritidis and Typhimurium are the most common serotypes and that efforts to reduce antimicrobial resistance among Salmonellain China are needed. Although no outbreaks were detected using this system, efforts to improve this system's capacity to do so are underway.
- Published
- 2011
- Full Text
- View/download PDF
225. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China
- Author
-
Wang, Hua, Feng, Zijian, Shu, Yuelong, Yu, Hongjie, Zhou, Lei, Zu, Rongqiang, Huai, Yang, Dong, Jie, Bao, Changjun, Wen, Leying, Wang, Hong, Yang, Peng, Zhao, Wei, Dong, Libo, Zhou, Minghao, Liao, Qiaohong, Yang, Haitao, Wang, Min, Lu, Xiaojun, Shi, Zhiyang, Wang, Wei, Gu, Ling, Zhu, Fengcai, Li, Qun, Yin, Weidong, Yang, Weizhong, Li, Dexin, Uyeki, Timothy M, and Wang, Yu
- Published
- 2008
- Full Text
- View/download PDF
226. Considerations for developing an immunization strategy with enterovirus 71 vaccine
- Author
-
Li, Li, Yin, Hongzhang, An, Zhijie, Feng, Zijian, and Vaccine
- Subjects
China ,medicine.medical_specialty ,Booster dose ,Disease ,Environmental health ,Immunology and Microbiology(all) ,Epidemiology ,medicine ,Enterovirus 71 ,Humans ,Clinical Trials as Topic ,General Veterinary ,General Immunology and Microbiology ,biology ,Hand, foot, and mouth disease ,Vaccine ,Immunization strategy ,business.industry ,Public Health, Environmental and Occupational Health ,Viral Vaccines ,Vaccine efficacy ,biology.organism_classification ,veterinary(all) ,Enterovirus A, Human ,Vaccination ,Clinical trial ,Infectious Diseases ,Immunization ,Immunology ,Molecular Medicine ,Hand, Foot and Mouth Disease ,business - Abstract
Enterovirus 71 (EV71) is a common pathogen for hand, foot, and mouth disease (HFMD), which has significant morbidity and mortality, and for which children aged 6–59 months age are at highest risk. Due to lack of effective treatment options, control of EV71 epidemics has mainly focused on development of EV71 vaccines. Clinical trials have been completed on 3 EV71 vaccines, with trial results demonstrating good vaccine efficacy and safety. When EV71 vaccine is approved by China's national regulatory authority, an evidence-based strategy should be developed to optimize impact and safety. An immunization strategy for EV71 vaccine should consider several factors, including the target population age group, the number of doses for primary immunization, the need for a booster dose, concomitant administration of other vaccines, economic value, program capacity and logistics, and public acceptance. Once EV71 vaccines are in use, vaccine effectiveness and safety must be monitored in large populations, and the epidemiology of HFMD must be evaluated to assure a match between vaccination strategy and epidemiology. Evaluation in China is especially important because there are no other EV71 vaccines globally.
- Full Text
- View/download PDF
227. Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial
- Author
-
Li, Yan, Gao, Fan, Wang, Yamin, Li, Jing, Zhang, Yuxi, Lv, Huakun, Wang, Shenyu, Yang, Haitao, Liu, Xiaoqiang, Li, Keli, Wang, Huaqing, Yin, Zundong, Liang, Zhenglun, An, Zhijie, Mao, Qunying, and Feng, Zijian
- Abstract
China's three inactivated enterovirus A71 (EV-A71) vaccines are the first and currently world's only EV-A71 vaccines approved by a national regulatory authority and used to prevent EV-A71 associated diseases. The three vaccines vary by vaccine strain, manufacturing cell substrate, and antigen dose, but no head-to-head comparisons of these vaccines have been done. We compared immunogenicity of the vaccines in children 6-35 months old.
- Published
- 2021
- Full Text
- View/download PDF
228. Influenza Vaccine Effectiveness in Mainland China: A Systematic Review and Meta-Analysis.
- Author
-
Yang, Xiaokun, Zhao, Hongting, Li, Zhili, Zhu, Aiqin, Ren, Minrui, Geng, Mengjie, Li, Yu, Qin, Ying, Feng, Luzhao, Peng, Zhibin, An, Zhijie, Zheng, Jiandong, Li, Zhongjie, and Feng, Zijian
- Subjects
FLU vaccine efficacy ,INFLUENZA vaccines ,INFLUENZA ,PUBLICATION bias - Abstract
Influenza endangers human health but can be prevented in part by vaccination. Assessing influenza vaccine effectiveness (VE) provides scientific evidence for developing influenza vaccination policy. We conducted a systematic review and meta-analysis of studies that evaluated influenza VE in mainland China. We searched six relevant databases as of 30 August 2019 to identify studies and used Review Manager 5.3 software to analyze the included studies. The Newcastle–Ottawa scale was used to assess the risk of publication bias. We identified 1408 publications, and after removing duplicates and screening full texts, we included 21 studies in the analyses. Studies were conducted in Beijing, Guangzhou, Suzhou, and Zhejiang province from the 2010/11 influenza season through the 2017/18 influenza season. Overall influenza VE for laboratory confirmed influenza was 36% (95% CI: 25–46%). In the subgroup analysis, VE was 45% (95% CI: 18–64%) for children 6–35 months who received one dose of influenza vaccine, and 57% (95% CI: 50–64%) who received two doses. VE was 47% (95% CI: 39–54%) for children 6 months to 8 years, and 18% (95% CI: 0–33%) for adults ≥60 years. For inpatients, VE was 21% (95% CI: −11–44%). We conclude that influenza vaccines that were used in mainland China had a moderate effectiveness, with VE being higher among children than the elderly. Influenza VE should be continuously monitored in mainland China to provide evidence for policy making and improving uptake of the influenza vaccine. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
229. Novel recoverable porous magnetic carbons derived from biobased polybenzoxazine by self-foaming and activation treatment.
- Author
-
Feng, Zijian, Zeng, Ming, Meng, Dawei, Zhu, Wanlin, Liu, Yuhui, and Huang, Xuqiao
- Subjects
- *
ADSORPTION kinetics , *CARBON foams , *ADSORPTION isotherms , *CHEMICAL structure , *ADSORPTION capacity , *MAGNETIC materials , *METHYLENE blue , *MAGNETIC separation - Abstract
• Novel recoverable porous magnetic carbons based on benzoxazine are fabricated. • Relationship between chemical structure and adsorption properties is clarified. • Porous magnetic carbon adsorbents exhibit good adsorption capacity of cationic dye. • Adsorption kinetics and adsorption isotherms of porous magnetic carbons are studied. The novel fully biobased polybenzoxazine derived carbon adsorbents containing Fe 3 O 4 magnetic nanoparticles are prepared by solvothermal method, followed by activation and carbonization treatments. There are the polymerization and self-foaming reactions of benzoxazine monomers, and thermal decomposition of Ferrous acetylacetonate during in situ preparation of magnetic carbon precursors. The designed and fabricated pentanoic acid type benzoxazine resin not only provides the rich oxygen-containing functional groups but also favors the development of porous structure for the resulting carbon materials. Both self-foaming reaction and activation treatment also benefit the formation of porous structure and improve the specific surface area. The dye adsorption performance, magnetic separability and recyclability of the fabricated carbon materials are investigated through selecting methylene blue as a cationic dye. The magnetic carbon materials occupy good adsorption capacity of cationic dye, resulting from rich oxygen-containing groups, relatively high specific surface area, and well-developed porous microstructure. The adsorption behavior of porous carbon adsorbents is fast, pH-sensitive, Langmuir monolayer adsorption mechanism, and better fitted to pseudo-second-order kinetic model. Moreover, easy magnetic separation and fast regeneration make the magnetic adsorbents suitable to be practically applied in wastewater treatment. Therefore, the flexible and effective strategy in this work may be generally applicable for the structural design and preparation of polymer derived magnetic carbon materials. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
230. Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
- Author
-
An, Zhijie, Wang, Fuzhen, Pan, An, Yin, Zundong, Rodewald, Lance, and Feng, Zijian
- Published
- 2021
- Full Text
- View/download PDF
231. Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: an open-label, randomized, controlled trial
- Author
-
Wang, Yamin, Xu, Qing, Jeyaseelan, Vishali, Ying, Zhifang, Mach, Ondrej, Sutter, Roland, Wen, Ning, Rodewald, Lance, Li, Changgui, Wang, Jie, Yuan, Hui, Yin, Zundong, Feng, Zijian, Xu, Aiqiang, and An, Zhijie
- Abstract
We assessed immunogenicity of three-dose and two-dose immunisation schedules with a Sabin-strain inactivated poliovirus vaccine (sIPV) produced by one Chinese vaccine manufacturer.
- Published
- 2021
- Full Text
- View/download PDF
232. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China
- Author
-
Li, Zhongjie, Guan, Xuhua, Mao, Naiying, Luo, Huiming, Qin, Ying, He, Na, Zhu, Zhen, Yu, Jianxing, Li, Yu, Liu, Jianhua, An, Zhijie, Gao, Wenjing, Wang, Xiaoli, Sun, Xiaodong, Song, Tie, Yang, Xingfen, Wu, Ming, Wu, Xianping, Yao, Wenqing, Peng, Zhibin, Sun, Junling, Wang, Liping, Guo, Qing, Xiang, Nijian, Liu, Jun, Zhang, Bike, Su, Xuemei, Rodewald, Lance, Li, Liming, Xu, Wenbo, Shen, Hongbing, Feng, Zijian, and Gao, George F
- Abstract
: China implemented containment measures to stop SARS-CoV-2 transmission in response to the COVID-19 epidemic. After the first epidemic wave, we conducted population-based serological surveys to determine extent of infection, risk factors for infection, and neutralization antibody levels to assess the real infections in the random sampled population.
- Published
- 2021
- Full Text
- View/download PDF
233. Lessons from an active surveillance pilot to assess the pneumonia of unknown etiology surveillance system in China, 2016: the need to increase clinician participation in the detection and reporting of emerging respiratory infectious diseases.
- Author
-
Xiang, Nijuan, Song, Ying, Wang, Yu, Wu, Jiabing, Millman, Alexander J., Greene, Carolyn M., Ding, Zhentao, Sun, Jie, Yang, Wei, Guo, Guoxia, Wang, Ruirui, Guo, Ping, Ren, Zhixing, Gong, Lei, Xu, Pengpeng, Zhou, Suizan, Lin, Dan, Ni, Daxin, Feng, Zijian, and Li, Qun
- Subjects
ETIOLOGY of pneumonia ,RESPIRATORY infections ,EMERGING infectious diseases ,SEASONAL influenza ,AVIAN influenza ,COMMUNICABLE diseases - Abstract
Background: We sought to assess reporting in China's Pneumonia of Unknown Etiology (PUE) passive surveillance system for emerging respiratory infections and to identify ways to improve the PUE surveillance system's detection of respiratory infections of public health significance.Methods: From February 29-May 29, 2016, we actively identified and enrolled patients in two hospitals with acute respiratory infections (ARI) that met all PUE case criteria. We reviewed medical records for documented exposure history associated with respiratory infectious diseases, collected throat samples that were tested for seasonal and avian influenza, and interviewed clinicians regarding reasons for reporting or not reporting PUE cases. We described and analyzed the proportion of PUE cases reported and clinician awareness of and practices related to the PUE system.Results: Of 2619 ARI admissions in two hospitals, 335(13%) met the PUE case definition; none were reported. Of 311 specimens tested, 18(6%) were seasonal influenza virus-positive; none were avian influenza-positive. < 10% PUE case medical records documented whether or not there were exposures to animals or others with respiratory illness. Most commonly cited reasons for not reporting cases were no awareness of the PUE system (76%) and not understanding the case definition (53%).Conclusions: Most clinicians have limited awareness of and are not reporting to the PUE system. Exposures related to respiratory infections are rarely documented in medical records. Increasing clinicians' awareness of the PUE system and including relevant exposure items in standard medical records may increase reporting. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
234. Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance.
- Author
-
Xiao, Cheng, Huang, Yonglian, Gao, Qiyuan, Feng, Zijian, Li, Qi, and Liu, Zhen
- Subjects
PAPILLARY carcinoma ,THYROID cancer ,PROTEIN expression ,LYMPH nodes - Abstract
Background: The abnormal expression of activator protein-1(AP-1) has recently been investigated in a variety of tumors. While the relationship between AP-1 and thyroid cancer is poorly studied, our study was to evaluate the protein expression and clinical value of AP-1 in papillary thyroid carcinoma (PTC). Methods: The expression of AP-1 was examined by immunohistochemistry on paraffin-embedded tissues obtained from PTC and correspondent paracancerous tissues of 82 patients. Results: Compared with paracancerous tissues, AP-1 expression was significantly elevated in PTC tissues and the positive rate was 79.3% (65/82). Our study found a linear trend relationship between the expression of AP-1 and tumor size. However, the differences in AP-1 expression among gender, age, lymph node metastasis, number of lesions, location of the lesion, and extrathyroid invasion are not statistically significant. Conclusions: The expression of AP-1 plays an important role in the proliferation process of PTC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
235. Trend analysis and prediction of gonorrhea in mainland China based on a hybrid time series model.
- Author
-
Wang, Zhende, Wang, Yongbin, Zhang, Shengkui, Wang, Suzhen, Xu, Zhen, and Feng, ZiJian
- Subjects
- *
BOX-Jenkins forecasting , *GONORRHEA , *TIME series analysis , *TREND analysis , *STANDARD deviations - Abstract
Background: Gonorrhea has long been a serious public health problem in mainland China that requires attention, modeling to describe and predict its prevalence patterns can help the government to develop more scientific interventions. Methods: Time series (TS) data of the gonorrhea incidence in China from January 2004 to August 2022 were collected, with the incidence data from September 2021 to August 2022 as the validation. The seasonal autoregressive integrated moving average (SARIMA) model, long short-term memory network (LSTM) model, and hybrid SARIMA-LSTM model were used to simulate the data respectively, the model performance were evaluated by calculating the mean absolute percentage error (MAPE), root mean square error (RMSE), and mean absolute error (MAE) of the training and validation sets of the models. Results: The Seasonal components after data decomposition showed an approximate bimodal distribution with a period of 12 months. The three models identified were SARIMA(1,1,1) (2,1,2)12, LSTM with 150 hidden units, and SARIMA-LSTM with 150 hidden units, the SARIMA-LSTM model fitted best in the training and validation sets, for the smallest MAPE, RMSE, and MPE. Conclusions: The overall incidence trend of gonorrhea in mainland China has been on the decline since 2004, with some periods exhibiting an upward trend. The incidence of gonorrhea displays a seasonal distribution, typically peaking in July and December each year. The SARIMA model, LSTM model, and SARIMA-LSTM model can all fit the monthly incidence time series data of gonorrhea in mainland China. However, in terms of predictive performance, the SARIMA-LSTM model outperforms the SARIMA and LSTM models, with the LSTM model surpassing the SARIMA model. This suggests that the SARIMA-LSTM model can serve as a preferred tool for time series analysis, providing evidence for the government to predict trends in gonorrhea incidence. The model's predictions indicate that the incidence of gonorrhea in mainland China will remain at a high level in 2024, necessitating that policymakers implement public health measures in advance to prevent the spread of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
236. Spatial analysis of county-based gonorrhoea incidence in mainland China, from 2004 to 2009.
- Author
-
Yin, Fei, Feng, Zijian, and Li, Xiaosong
- Abstract
The article discusses a research study which presented a spatial analysis of county-based gonorrhoea incidence in mainland China from 2004-2009. Results revealed 12.42 cases per 100,000 people as the average annual gonorrhoea incidence during the six-year study period. Bayesian smoothing and exploratory spatial data analysis (ESDA) methods were found to be effective methods for characterizing the spatial distribution of gonorrhoea cases and for assisting public health officials in identifying high-risk areas to reduce incidence. The higher incidence rates for four counties in eastern coastal regions, particularly Shanghai, Zhejiang and Jiangsu provinces, were indicated using the local Moran cluster map and associated to increased demand for commercial sex in urban areas.
- Published
- 2012
- Full Text
- View/download PDF
237. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
- Author
-
Yu, Hongjie, Liao, Qiaohong, Yuan, Yuan, Zhou, Lei, Xiang, Nijuan, Huai, Yang, Guo, Xiuhua, Zheng, Yingdong, van Doorn, H. Rogier, Farrar, Jeremy, Gao, Zhancheng, Feng, Zijian, Wang, Yu, and Yang, Weizhong
- Subjects
DISEASE progression ,H1N1 influenza ,DRUG efficacy ,PNEUMONIA ,RADIOGRAPHY - Abstract
The article offers information on a study which investigated the effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1 in China. The researchers reviewed medical data of 1291 patients with confirmed 2009 H1N1 from May to July 2009. Findings of the study are presented. It concludes that oseltamivir treatment is effective in protecting against the development of radiographic pneumonia and is related to shorter duration of fever and viral RNA shedding.
- Published
- 2010
- Full Text
- View/download PDF
238. Aptamer Probes Labeled with Lanthanide‐Doped Carbon Nanodots Permit Dual‐Modal Fluorescence and Mass Cytometric Imaging.
- Author
-
Yu, Youyi, Wang, Xin, Jia, Xiaolong, Feng, Zijian, Zhang, Lulu, Li, Hongxia, He, Jie, Shen, Guangxia, and Ding, Xianting
- Subjects
- *
FLUORESCENCE , *APTAMERS , *OPTICAL resolution , *PROTEIN fractionation , *CARBON - Abstract
High‐dimensional imaging mass cytometry (IMC) enables simultaneous quantification of over 35 biomarkers on one tissue section. However, its limited resolution and ultralow acquisition speed remain major issues for general clinical application. Meanwhile, conventional immunofluorescence microscopy (IFM) allows sub‐micrometer resolution and rapid identification of the region of interest (ROI), but only operates with low multiplicity. Herein, a series of lanthanide‐doped blue‐, green‐, and red‐fluorescent carbon nanodots (namely, B‐Cdots(Ln1), G‐Cdots(Ln2), and R‐Cdots(Ln3)) as fluorescence and mass dual‐modal tags are developed. Coupled with aptamers, B‐Cdots(159Tb)‐A10‐3.2, G‐Cdots(165Ho)‐AS1411, and R‐Cdots(169Tm)‐SYL3C dual‐functional aptamer probes, which are then multiplexed with commercially available Maxpar metal‐tagged antibodies for analyzing clinical formalin‐fixed, paraffin‐embedded (FFPE) prostatic adenocarcinoma (PaC) tissue, are further synthesized. The rapid identification of ROI with IFM using fluorescence signals and subsequent multiplexed detection of in situ ROI with IMC using the same tissue section is demonstrated. Dual‐modal probes save up to 90% IMC blind scanning time for a standard 3.5 mm × 3.5 mm overall image. Meanwhile, the IFM provides refined details and topological spatial distributions for the functional proteins at optical resolution, which compensates for the low resolution of the IMC imaging. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
239. Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020.
- Author
-
Ren, Ruiqi, Zhang, Yanping, Li, Qun, McGoogan, Jennifer M., Feng, Zijian, Gao, George F., and Wu, Zunyou
- Subjects
- *
RESEARCH funding - Abstract
This population epidemiology study characterizes trends in the prevalence of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among international entrants testing positive for SARS-CoV-2 at Chinese border checkpoints between mid-April and mid-October 2020. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
240. Progress Toward Measles Elimination - China, January 2013-June 2019.
- Author
-
Ma, Chao, Rodewald, Lance, Hao, Lixin, Su, Qiru, Zhang, Yan, Wen, Ning, Fan, Chunxiang, Yang, Hong, Luo, Huiming, Wang, Huaqing, Goodson, James L, Yin, Zundong, and Feng, Zijian
- Abstract
In 2005, the World Health Organization (WHO) Western Pacific Region countries, including China, resolved to eliminate measles by 2012 or as soon as feasible thereafter (1). As of 2018, nine* of the 37 Western Pacific Region countries or areas† had eliminated§ measles. China's Measles Elimination Action Plan 2006-2012 included strengthening routine immunization; conducting measles risk assessments, followed by supplementary immunization activities (SIAs) with measles-containing vaccine (MCV) at national and subnational levels; strengthening surveillance and laboratory capacity; and investigating and responding to measles outbreaks. Most recently, progress toward measles elimination in China was described in a 2014 report documenting measles elimination efforts in China during 2008-2012 and a resurgence in 2013 (2). This report describes progress toward measles elimination in China during January 2013-June 2019.¶ Measles incidence per million persons decreased from 20.4 in 2013 to 2.8 in 2018; reported measles-related deaths decreased from 32 in 2015 to one in 2018 and no deaths in 2019 through June. Measles elimination in China can be achieved through strengthening the immunization program's existing strategy by ensuring sufficient vaccine supply; continuing to improve laboratory-supported surveillance, outbreak investigation and response; strengthening school entry vaccination record checks; vaccinating students who do not have documentation of receipt of 2 doses of measles-rubella vaccine; and vaccinating health care professionals and other adults at risk for measles. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
241. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
- Author
-
Liu, Chenxi, Xiao, Cheng, Chen, Jianjia, Li, Xiangyang, Feng, Zijian, Gao, Qiyuan, and Liu, Zhen
- Subjects
- *
LYMPH nodes , *PAPILLARY carcinoma , *THYROID cancer , *DISEASE risk factors , *FACTOR analysis , *LYMPHADENECTOMY , *THYROIDECTOMY - Abstract
Backgrounds: The aim of this study is to investigate the risk factors for the cervical lymph node metastasis in papillary thyroid carcinoma (PTC).Methods: The clinicopathological data from the 966 PTC patients who underwent thyroid operation between January 2013 and December 2015 in the general surgery department of Shengjing Hospital of China Medical University were collected. The risk factors of predicting cervical lymph node metastasis were analyzed.Results: Male, age ≤ 45 years old, tumor size> 1.0 cm, extrathyroidal extension (ETE), US features as microcalcification, were independent risk factors for central lymph node metastasis (CLNM) (P < 0.05). Only CLNM was independent risk factors for lateral lymph node metastasis (LLNM) (P < 0.05). The ROC curve showed that the cutoff value of the number of CLNM for predicting lateral lymph node metastasis was defined as 2.5 (Sensitivity = 0.535, Specificity = 0.722, AUC = 0.669, P < 0.05). When the number of CLNM > 3, OR value was significantly higher, suggesting that the risk of LLNM increased significantly. The incidence of LLNM in level III (66.8%) and level IV (67.3%) were significantly higher than level II (42.2%) and level V (21.3%) (P < 0.05). The incidence of LLNM and skip metastasis in tumor located in the upper 1/3 of the lobe was the highest (P < 0.05).Conclusions: Prophylactic central lymph node dissection should be performed in patients with risk factors as male, age ≤ 45 years old, tumor size> 1.0 cm, ETE and US features as microcalcification. Lateral lymph node dissection (LLND) should be more actively performed in patients with the number of CLNM> 3. Extent of LLND should include levels II, III, IV and V. Tumor located in the upper 1/3 of the lobe was vulnerable for LLNM and skip metastasis, so lymph node in lateral compartment should be noticed when lymph node status was preoperatively evaluated by imaging examination. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
242. Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial.
- Author
-
Li, Yan, Chu, Susan Y, Yue, Chenyan, Wannemuehler, Kathleen, Xie, Shuyun, Zhang, Fubin, Wang, Yamin, Zhang, Yuxi, Ma, Rui, Li, Yumin, Zuo, Zhiping, Rodewald, Lance, Xiao, Qiyou, Feng, Zijian, Wang, Huaqing, and An, Zhijie
- Subjects
- *
RUBELLA , *JAPANESE B encephalitis , *EMERGING infectious diseases , *POSTVACCINAL encephalitis , *INFANTS , *VACCINES - Abstract
Summary Background In China, measles-rubella vaccine and live attenuated SA 14–14–2 Japanese encephalitis vaccine (LJEV) are recommended for simultaneous administration at 8 months of age, which is the youngest recommended age for these vaccines worldwide. We aimed to assess the effect of the co-administration of these vaccines at 8 months of age on the immunogenicity of measles-rubella vaccine. Methods We did a multicentre, open-label, non-inferiority, two-group randomised controlled trial in eight counties or districts in China. We recruited healthy infants aged 8 months who had received all scheduled vaccinations according to the national immunisation recommendations and who lived in the county of the study site. Enrolled infants were randomly assigned (1:1) to receive either measles-rubella vaccine and LJEV simultaneously (measles-rubella plus LJEV group) or measles-rubella vaccine alone (measles-rubella group). The primary outcome was the proportion of infants with IgG antibody seroconversion for measles 6 weeks after vaccination, and a secondary outcome was the proportion of infants with IgG antibody seroconversion for rubella 6 weeks after vaccination. Analyses included all infants who completed the study. We used a 5% margin to establish non-inferiority. This trial was registered at ClinicalTrials.gov (NCT02643433). Findings 1173 infants were assessed for eligibility between Aug 13, 2015, and June 10, 2016. Of 1093 (93%) enrolled infants, 545 were randomly assigned to the measles-rubella plus LJEV group and 548 to the measles-rubella group. Of the infants assigned to each group, 507 in the measles-rubella plus LJEV group and 506 in the measles-rubella group completed the study. Before vaccination, six (1%) of 507 infants in the measles-rubella plus LJEV group and one (<1%) of 506 in the measles-rubella group were seropositive for measles; eight (2%) infants in the measles-rubella plus LJEV group and two (<1%) in the measles-rubella group were seropositive for rubella. 6 weeks after vaccination, measles seroconversion in the measles-rubella plus LJEV group (496 [98%] of 507) was non-inferior to that in the measles-rubella group (499 [99%] of 506; difference −0·8% [90% CI −2·6 to 1·1]) and rubella seroconversion in the measles-rubella plus LJEV group (478 [94%] of 507) was non-inferior to that in the measles-rubella group (473 [94%] of 506 infants; difference 0·8% [90% CI −1·8 to 3·4]). There were no serious adverse events in either group and no evidence of a difference between the two groups in the prevalence of any local adverse event (redness, rashes, and pain) or systemic adverse event (fever, allergy, respiratory infections, diarrhoea, and vomiting). Fever was the most common adverse event (97 [19%] of 507 infants in the measles-rubella plus LJEV group; 108 [21%] of 506 infants in the measles-rubella group). Interpretation The evidence of similar seroconversion and safety with co-administered LJEV and measles-rubella vaccines supports the co-administration of these vaccines to infants aged 8 months. These results will be important for measles and rubella elimination and the expansion of Japanese encephalitis vaccination in countries where it is endemic. Funding US Centers for Disease Control and Prevention, US Department of Health and Human Services; China–US Collaborative Program on Emerging and Re-emerging Infectious Diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
243. Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine.
- Author
-
Su, Qiru, Ma, Chao, Wen, Ning, Fan, Chunxiang, Yang, Hong, Wang, Huaqing, Yin, Zundong, Feng, Zijian, Hao, Lixin, and Yang, Weizhong
- Subjects
- *
RUBELLA vaccines , *IMMUNIZATION , *EPIDEMIOLOGY , *MEASLES vaccines , *VACCINATION , *VACCINE effectiveness - Abstract
Background Rubella-containing vaccine (RCV) became available in China in 1993 and was introduced nationwide into the Expanded Immunization Program (EPI) in 2008. We evaluated implementation and impact of RCV from 2 years prior to nationwide introduction through the 10 years after nationwide introduction. Methods We analyzed RCV lot-release (doses distributed) data, 1- and 2-dose RCV coverage, and rubella data from China’s nationwide disease surveillance system to describe the current status and changes in rubella epidemiology between 2005 and 2017. Results While the vaccine was included into the routine immunization program in 2008, its full implementation required 4 years due to sporadic vaccine supply constraints. RCV1 and RCV2 coverage increased from 51.5% and 39.0% in 2008 to >95% during 2012 through 2016. From 2005 to 2017, the annual incidences (per million) of rubella ranged from 91.09 in 2008 down to 1.16 in 2017; reductions occurred in all age groups. The proportion of cases among individuals ≥20 years old increased from 0.97% in 2005 to 31.2% in 2017. In the better-developed eastern China, most cases were among adults; in central and western China, most cases were among children or adolescents. Conclusions The marked decrease rubella was a result of inclusion of RCVs into EPI targeting children less than 2 years of age and achieving high level of 2-dose coverage. Rubella was reduced in absolute terms, and its epidemiology was changed to older cases with substantial inter-province variation. Ensuring full vaccination of school children and identifying strategies to reach adults with measles and rubella combined vaccines will be important to hasten elimination of rubella and prevent CRS outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
244. Synthesis, polymerization kinetics, and high-frequency dielectric properties of novel main-chain benzoxazine copolymers.
- Author
-
Xu, Qingyu, Zeng, Ming, Chen, Jiangbing, Zeng, Shengguo, Huang, Yiwan, Feng, Zijian, Xu, Qingqiang, Yan, Chunjie, and Gu, Yi
- Subjects
- *
POLYMERIZATION kinetics , *DIELECTRIC properties of polymeric composites , *BENZOXAZINES , *COPOLYMERS , *MANNICH reaction - Abstract
Novel aromatic main-chain benzoxazine copolymer oligomers are synthesized by the Mannich reaction. Cured main-chain benzoxazine copolymers possess improved processing and high-frequency dielectric properties in comparison with corresponding main-chain benzoxazines, owing to the decreased molecular polarity and molecular weight. It should be noted that the polar/nonpolar heterogeneous solvent indeed plays a key role in the preparation of main-chain copolymer oligomers. The copolymers prepared in the optimized heterogeneous solvent condition has the least activation energy, the minimum high-frequency dielectric constants (2.81, 5 GHz; 2.75, 10 GHz), and a relatively high glass transition temperature (260 °C). Therefore, this work not only provides a simple path for improving processing and high-frequency dielectric properties of main-chain benzocaine but also gives some insight into the effects of solvent on the formation of copolymers. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
245. Feature-aware conditional GAN for category text generation.
- Author
-
Li, Xinze, Mao, Kezhi, Lin, Fanfan, and Feng, Zijian
- Subjects
- *
NATURAL language processing , *GENERATIVE adversarial networks - Abstract
Category text generation receives considerable attentions since it is beneficial for various natural language processing tasks. Recently, the generative adversarial network (GAN) has attained promising performance in text generation, attributed to its adversarial training process. However, there are several issues in text GANs, including discreteness, training instability, mode collapse, lack of diversity and controllability etc. To address these issues, this paper proposes a novel GAN framework, the feature-aware conditional GAN (FA-GAN), for controllable category text generation. In FA-GAN, the generator has a sequence-to-sequence structure for improving sentence diversity, which consists of three encoders including a special feature-aware encoder and a category-aware encoder, and one relational-memory-core-based decoder with the Gumbel SoftMax activation function. The discriminator has an additional category classification head. To generate sentences with specified categories, the multi-class classification loss is supplemented in the adversarial training. Comprehensive experiments have been conducted, and the results show that FA-GAN consistently outperforms 10 state-of-the-art text generation approaches on 6 text classification datasets. The case study demonstrates that the synthetic sentences generated by FA-GAN can match the required categories and are aware of the features of conditioned sentences, with good readability, fluency, and text authenticity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
246. Considerations for developing an immunization strategy with enterovirus 71 vaccine.
- Author
-
Li, Li, Yin, Hongzhang, An, Zhijie, and Feng, Zijian
- Subjects
- *
FOOT & mouth disease , *IMMUNIZATION , *ENTEROVIRUSES , *PATHOGENIC microorganisms , *MORTALITY , *EPIDEMIOLOGY - Abstract
Enterovirus 71 (EV71) is a common pathogen for hand, foot, and mouth disease (HFMD), which has significant morbidity and mortality, and for which children aged 6–59 months age are at highest risk. Due to lack of effective treatment options, control of EV71 epidemics has mainly focused on development of EV71 vaccines. Clinical trials have been completed on 3 EV71 vaccines, with trial results demonstrating good vaccine efficacy and safety. When EV71 vaccine is approved by China's national regulatory authority, an evidence-based strategy should be developed to optimize impact and safety. An immunization strategy for EV71 vaccine should consider several factors, including the target population age group, the number of doses for primary immunization, the need for a booster dose, concomitant administration of other vaccines, economic value, program capacity and logistics, and public acceptance. Once EV71 vaccines are in use, vaccine effectiveness and safety must be monitored in large populations, and the epidemiology of HFMD must be evaluated to assure a match between vaccination strategy and epidemiology. Evaluation in China is especially important because there are no other EV71 vaccines globally. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
247. Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013.
- Author
-
Xiang, Nijuan, Havers, Fiona, Chen, Tao, Song, Ying, Tu, Wenxiao, Li, Leilei, Cao, Yang, Liu, Bo, Zhou, Lei, Meng, Ling, Hong, Zhiheng, Wang, Rui, Niu, Yan, Yao, Jianyi, Liao, Kaiju, Jin, Lianmei, Zhang, Yanping, Li, Qun, Widdowson, Marc-Alain, and Feng, Zijian
- Abstract
In mainland China, most avian influenza A(H7N9) cases in the spring of 2013 were reported through the pneumonia of unknown etiology (PUE) surveillance system. To understand the role of possible underreporting and surveillance bias in assessing the epidemiology of subtype H7N9 cases and the effect of live-poultry market closures, we examined all PUE cases reported from 2004 through May 3, 2013. Historically, the PUE system was underused, reporting was inconsistent, and PUE reporting was biased toward A(H7N9)-affected provinces, with sparse data from unaffected provinces; however, we found no evidence that the older ages of persons with A(H7N9) resulted from surveillance bias. The absolute number and the proportion of PUE cases confirmed to be A(H7N9) declined after live-poultry market closures (p<0.001), indicating that market closures might have positively affected outbreak control. In China, PUE surveillance needs to be improved. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
248. Transmission Dynamics, Border Entry Screening, and School Holidays during the 2009 Influenza A (H1N1) Pandemic, China.
- Author
-
Yu, Hongjie, Cauchemez, Simon, Donnelly, Christl A., Zhou, Lei, Feng, Luzhao, Xiang, Nijuan, Zheng, Jiandong, Ye, Min, Huai, Yang, Liao, Qiaohong, Peng, Zhibin, Feng, Yunxia, Jiang, Hui, Yang, Weizhong, Wang, Yu, Ferguson, Neil M., and Feng, Zijian
- Subjects
- *
INFLUENZA A virus , *VIRUS diseases , *REPRODUCTION , *EPIDEMIC research , *RESPIRATORY infections - Abstract
Pandemic influenza A (H1N1) 2009 virus spread rapidly around the world in 2009. We used multiple data sources from surveillance systems and specific investigations to characterize the transmission patterns of this virus in China during May-November 2009 and analyze the effectiveness of border entry screening and holiday-related school closures on transmission. In China, age distribution and transmission dynamic characteristics were similar to those in Northern Hemisphere temperate countries. The epidemic was focused in children, with an effective reproduction number of ≈1.2-1.3. The 8 days of national holidays in October reduced the effective reproduction number by 37% (95% credible interval 28%-45%) and increased underreporting by ≈20%-30%. Border entry screening detected at most 37% of international travel-related cases, with most (89%) persons identified as having fever at time of entry. These findings suggest that border entry screening was unlikely to have delayed spread in China by >4 days. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
249. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.
- Author
-
Lin, Jiangtao, Zhang, Jiansan, Dong, Xiaoping, Fang, Hanhua, Chen, Jiangting, Su, Nan, Gao, Qiang, Zhang, Zhenshan, Liu, Yuxuan, Wang, Zhihong, Yang, Meng, Sun, Ruihua, Li, Changgui, Lin, Su, Ji, Mei, Liu, Yan, Wang, Xu, Wood, John, Feng, Zijian, and Wang, Yu
- Subjects
- *
CLINICAL trials , *VACCINATION , *PREVENTIVE medicine , *INFLUENZA , *AVIAN influenza , *IMMUNE response , *MEDICAL research - Abstract
Summary Background Avian influenza A virus H5N1 has caused widespread infections that have resulted in severe disease or death in poultry and wild birds as well as human beings. This virus has the potential to emerge as a pandemic threat and H5N1 vaccines are being developed in many countries. Our aim was to assess the safety and immunogenicity of an inactivated adjuvanted whole-virion H5N1 vaccine. Methods A stratified randomised, placebo-controlled, double-blind phase I clinical trial was done in 120 volunteers aged 18-60 years. Volunteers were assigned to receive two doses of placebo (n=24) or an inactivated whole-virion influenza A (H5N1) vaccine with 1·25 μg (24), 2·5 μg (24), 5 μg (24), or 10 μg (24) haemagglutinin per dose with aluminium hydroxide adjuvant on day 0 and 28. Serum samples were obtained on day 0, 14, 28, 42, and 56 for haemagglutination inhibition and virus neutralisation assays. This trial is registered with the ClinicalTrials.gov registry with the number NCT00356798. Findings All four formulations of vaccines were well tolerated. No serious adverse event was reported and most local and systemic reactions were mild and transient. All formulations induced antibody responses after the first dose; the highest immune response of 78% seropositivity was seen in the 10 μg group after two vaccine doses. Two individuals dropped out: one in the 1·25 μg group (withdrew consent) and one in the 10 μg group (discontinued); one individual was also excluded from the final analysis. Interpretation A two-dose regimen of an adjuvanted 10 μg inactivated whole-virion H5N1 vaccine met all European regulatory requirements for annual licensing of seasonal influenza vaccine. Lower doses of this vaccine could achieve immune responses equivalent to those elicited by adjuvanted or non-adjuvanted split-virion vaccines. The use of a whole virion vaccine could be more adaptable to the antigen-sparing strategy recommended by WHO for protection against an influenza pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
250. Silver microspheres aggregation-induced Raman enhanced scattering used for rapid detection of carbendazim in Chinese tea.
- Author
-
He, Jie, Li, Hongxia, Zhang, Lulu, Zhi, Xiao, Li, Xin, Wang, Xin, Feng, Zijian, Shen, Guangxia, and Ding, Xianting
- Subjects
- *
SURFACE enhanced Raman effect , *RAMAN scattering , *SERS spectroscopy , *PESTICIDE residues in food , *SILVER , *GLASS coatings , *PREPARED foods , *TEA trade - Abstract
• We invented a technology of an easy-prepared and low-cost chip consisting of 3D silver microspheres (AgMSs). • The aggregation of micron-sized silver particles can induce much more hotspots of enhanced Raman scattering. • We proposed that Raman enhancement mechanism of 3D silver microspheres lay in the 3D synergetic effects. • We demonstrated the trace detection of pesticide residue in Chinses tea. Due to the excessive use of fungicides, pesticide residues have become a growing concern in recent years. Herein, we demonstrated an easy-prepared and low-cost surface enhanced Raman Scattering (SERS) chip composed of 3D silver microspheres (AgMSs) pattern for the quantitative testing of carbendazim in Chinese tea. Compared with the common monolayer SERS substrate, the 3D patterns formed by self-assembly AgMSs with fine nanostructure can offer much more aggregation-induced hotspots and generate strong 3D synergetic effects. Furthermore, when the thickness of the 3D pattern exceeded 6 μm, we replaced the conductive supporting coatings using the glass slides to reduce the cost without any impact on SERS properties. The prepared 3D chips achieved the determination of carbendazim within the linear range of 0.1–10 mg/L and the detection limit of 0.01 mg/L. It is simple and sensitive enough for the detection of most pesticide residues or other harmful organic molecules in our food or environment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.